Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Neuroleptic Malignant Syndrome

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Neuroleptic Malignant Syndrome:

Pubmed Logo
Malignant syndrome in Parkinson's disease without dopaminergic drug withdrawal.
Malignant syndrome is a rare complication occurring during the course of...
7th November, 2009
Department of Neurology, Kerala Institute of Medical Sciences, Trivandrum, Ann Indian Acad Neurol. 2008 Oct;11(4):248-50.
DOI Direct Link
Neuroleptic malignant syndrome and acute motor axonal neuropathy after Campylobacter jejuni infection.
We report the case of a patient with Parkinson's disease who developed...
5th November, 2009
Department of Neurology, Neuromuscular Clinic, Leicester General Hospital, Neurophysiol Clin. 2009 Aug;39(3):135-8. Epub 2009 Mar 17.
DOI Direct Link
Prevalence of neuroleptic malignant syndrome in 672 consecutive male in-patients.
Background: Neuroleptic malignant syndrome (NMS) is the most serious and...
3rd November, 2009
Department of Psychiatry, Command Hospital, Alipore, Kolkata, West Bengal, Indian J Psychiatry. 2009 Jul-Sep;51(3):202-5.
DOI Direct Link
Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
Neuroleptic malignant syndrome (NMS) is a potentially life-threatening...
30th October, 2009
Divisions of Neurological Surgery, Barrow Neurological Institue, St. J Neurosurg Pediatr. 2009 Sep;4(3):217-21.
DOI Direct Link
Neuroleptic malignant syndrome without withdrawal of levodopa.
Neuroleptic malignant syndrome (NMS) is a potentially life-threatening...
30th October, 2009
Natl Med J India. 2009 May-Jun;22(3):162.

View more research publications.

Press Releases About Neuroleptic Malignant Syndrome:

BioPortfolio Logo
DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 24th November, 2009 DynaVox Mayer-Johnson
PITTSBURGH, Nov. 24 /PRNewswire/ -- WHAT: Rom Houbens, a Belgian man thought to have been in coma for 23 years following an auto accident, was actually fully conscious and awake during that time and
Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 23rd November, 2009 Lexicon Pharmaceuticals, Inc.
THE WOODLANDS, Texas, Nov. 23 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that top-line data from its Phase 2 clinical study with LX1031 in patients with
Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R) 20th November, 2009 Merck & Co., Inc.
WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has
Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 18th November, 2009 Viron Therapeutics Inc.
VT-111 significantly reduces key cardiac enzymes at multiple time points after stent placement; Data presented at American Heart Association 2009 Scientific Sessions LONDON, ON, Nov. 18 /PRNewswire/
Oklahoma Medical Research Foundation Accelerates Discovery With Isilon IQ 18th November, 2009 Isilon Systems
SEATTLE, Nov. 18 /PRNewswire-FirstCall/ -- IsilonĀ® Systems (Nasdaq: ISLN) today announced that the Oklahoma Medical Research Foundation (OMRF), a nonprofit biomedical research institute, has

Neuroleptic Malignant Syndrome Patents:

USPTO Logo
US Patent No.Title
7179934 Amino acids with affinity for the .alpha.2.delta.-protein
7351692 Method and composition for potentiating the antipyretic action of a nonopioid analgesic
7351707 Spiroazacyclic compounds as monoamine receptor modulators
7381747 Alpha 2 delta ligands for post-traumatic stress disorder
7388023 Amino acids with affinity for the .alpha.2.delta.-protein

View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Neuroleptic Malignant Syndrome scientists - we have details of around 182 individuals working on Neuroleptic Malignant Syndrome .


This page has been viewed 492 times
Recent Search Terms used to find this page: Neuroleptic malignant syndrome without withdrawal of levodopa | Putative neuroleptic malignant syndrome | Putative Neuroleptic Malignant Syndrome | neuroleptic malignant syndrome nms | postneuroleptic malignant treatment | psychiatrists treating post neuroleptic malignant syndrome patients | Risperidon***e-induced hyperamylasemia hyperlipasemia and neuroleptic malignant syndrome | risperdal for excited delirium | Free download of article Neuroleptic malignant syndrome from central nervous system insult 4 cases and a novel treatment surgery | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Neuroleptic Malignant Syndrome across BioPortfolio, or for Neuroleptic Malignant Syndrome Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.